Detalhe da pesquisa
1.
Mind the target: programmed death ligand 1 in oesophagogastric cancers.
Curr Opin Oncol
; 34(4): 389-394, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787595
2.
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.
Gut
; 70(9): 1632-1641, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199443
3.
Gastric cancer.
Lancet
; 396(10251): 635-648, 2020 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861308
4.
Changes in the therapeutic landscape of oesophago-gastric cancers.
Curr Opin Oncol
; 33(4): 362-367, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33720069
5.
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins.
Acta Oncol
; 60(5): 672-680, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586602
6.
Multimodality treatment for localized gastric cancer: state of the art and new insights.
Curr Opin Oncol
; 32(4): 347-355, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541324
7.
Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancer.
Lancet
; 402(10418): 2168-2170, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871605
8.
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.
Surg Innov
; 25(2): 99-104, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29303062
9.
Targeting HER2 for localised oesophageal cancer.
Lancet Oncol
; 23(2): 188-190, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038428
10.
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Lancet Oncol
; 18(3): 357-370, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163000
11.
Chemoradiotherapy or Surgery for Very Early Esophageal Squamous Cancer: Can a Nonrandomized Trial Give Us the Answer?
Gastroenterology
; 161(6): 1793-1795, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536450
12.
Reply to: Letter to editor on the article "Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy".
Gastric Cancer
; 25(6): 1133-1135, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152122
13.
Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study.
BMC Cancer
; 16: 112, 2016 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883815
14.
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010.
Gastric Cancer
; 19(4): 1114-1124, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541768
15.
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?
Curr Treat Options Oncol
; 17(5): 21, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032643
16.
Chemotherapy for resectable microsatellite instability-high gastric cancer?
Lancet Oncol
; 21(2): 204, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007194
17.
The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Ann Surg Oncol
; 22(13): 4353-62, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25773876
18.
A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
J Surg Oncol
; 111(6): 768-70, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556724
19.
Adjuvant or neoadjuvant therapy for operable esophagogastric cancer?
Gastric Cancer
; 18(1): 1-10, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24638977
20.
Nivolumab for previously treated squamous oesophageal carcinoma.
Lancet Oncol
; 20(11): 1468-1469, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582356